Owens & Minor (NYSE:OMI) Downgraded by StockNews.com

Owens & Minor (NYSE:OMIGet Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Wednesday.

A number of other equities research analysts have also recently weighed in on the company. Zacks Investment Research cut Owens & Minor from a “buy” rating to a “hold” rating in a research note on Friday, May 6th. Citigroup assumed coverage on shares of Owens & Minor in a research note on Tuesday, April 26th. They set a “buy” rating on the stock. Finally, Credit Suisse Group lifted their target price on Owens & Minor from $42.00 to $43.00 and gave the company a “neutral” rating in a research report on Monday, February 28th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Owens & Minor presently has a consensus rating of “Hold” and a consensus price target of $49.80.

Shares of OMI stock opened at $37.62 on Wednesday. The stock has a market cap of $2.86 billion, a P/E ratio of 14.93, a price-to-earnings-growth ratio of 1.32 and a beta of 0.46. Owens & Minor has a one year low of $29.85 and a one year high of $49.16. The stock has a fifty day moving average price of $41.56 and a 200 day moving average price of $41.84. The company has a debt-to-equity ratio of 2.78, a current ratio of 1.54 and a quick ratio of 0.61.

Owens & Minor (NYSE:OMIGet Rating) last posted its earnings results on Tuesday, May 3rd. The company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.19. The firm had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.31 billion. Owens & Minor had a return on equity of 29.89% and a net margin of 1.94%. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.57 earnings per share. Equities research analysts anticipate that Owens & Minor will post 3.35 EPS for the current year.

In other Owens & Minor news, Director Robert J. Henkel purchased 2,000 shares of Owens & Minor stock in a transaction that occurred on Monday, May 2nd. The stock was acquired at an average price of $35.00 per share, with a total value of $70,000.00. Following the transaction, the director now owns 26,000 shares in the company, valued at approximately $910,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 4.09% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of OMI. National Bank of Canada FI grew its holdings in Owens & Minor by 168.7% during the first quarter. National Bank of Canada FI now owns 583 shares of the company’s stock worth $26,000 after buying an additional 366 shares in the last quarter. EverSource Wealth Advisors LLC bought a new position in shares of Owens & Minor during the fourth quarter valued at about $28,000. CWM LLC purchased a new position in Owens & Minor during the fourth quarter worth about $31,000. US Asset Management LLC bought a new stake in Owens & Minor in the 1st quarter worth about $34,000. Finally, GHP Investment Advisors Inc. purchased a new stake in Owens & Minor in the 1st quarter valued at about $54,000. 95.69% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Company Profile (Get Rating)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

Read More

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.